Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

TVF Communications

- PMLiVE

World Castleman Disease Day

Thursday 23 July marks World Castleman Disease Day. Castleman disease (CD) is the name given to a group of rare and life-threatening lymphoproliferative disorders that affect the lymph nodes and...

- PMLiVE

A time of change, a time to change?

By Sally Bull and Stephen Small

- PMLiVE

Acadia’s Nuplazid misses the mark in major depressive disorder trial

Company's efforts to extend drug's reach fall flat

- PMLiVE

New faces at HCA, PSL Group and Health Unlimited

New board structure announced at HCA and a new MD appointed at Health Unlimited

- PMLiVE

EMA to support real-world monitoring of COVID-19 treatments/vaccines

New infrastructure will support real-world studies

- PMLiVE

Gilead makes a play for novel cancer drug with Tizona deal

Pharma company continues oncology biotech spending spree

Onyx Health Expands with New Management Appointment

Onyx Health have continued to grow throughout the COVID-19 downturn and have expanded the agency further by appointing Alix Stonehouse as their new Account Manager

Onyx Health

- PMLiVE

China’s CanSino Biologics reveals phase 2 coronavirus vaccine results

Candidate induced neutralising antibody responses

- PMLiVE

Novartis stumbles in Q2 as COVID-19 impacts sales

Net profit drops by 4% as pandemic hits sales

AstraZeneca AZ

AZ/Oxford’s COVID-19 vaccine proves promising in early trials

Vaccine candidate produced robust immune response

- PMLiVE

Media Means Business

Creating meaningful media experiences in pharma

Havas Lynx

- PMLiVE

UK agrees further COVID-19 vaccine deals with Pfizer/BioNTech, Valneva

Government has already agreed similar deal with AstraZeneca

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links